Artiva Biotherapeutics | SC 13G:超過5%持股股東披露文件-venBio Global Strategic Fund III, L.P.(7.8%),venBio Global Strategic GP III, L.P.(7.8%)等
Artiva Biotherapeutics | SC 13G:超過5%持股股東披露文件-Andrew J. Schwab(10.1%),Kush Parmar(10.1%)等
Artiva Biotherapeutics | SC 13G:超過5%持股股東披露文件-Venrock Healthcare Capital Partners III, L.P.(6.9%),VHCP Co-Investment Holdings III, LLC(6.9%)等
Artiva Biotherapeutics | SC 13D:超過5%持股股東披露文件-RA Capital Management, L.P.(42.3%),Peter Kolchinsky(42.3%)等
Artiva Biotherapeutics | SC 13D:超過5%持股股東披露文件-GC Corp.(19.6%),Yong-Jun Huh(19.6%)等
Artiva Biotherapeutics | 4:持股變動聲明-董事 RA CAPITAL MANAGEMENT, L.P.
Artiva Biotherapeutics | 4:持股變動聲明-股東 5AM Partners VI, LLC
Artiva Biotherapeutics | 4:持股變動聲明-股東 Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Artiva Biotherapeutics | 4:持股變動聲明-股東 venBio Global Strategic Fund III, L.P.
Artiva Biotherapeutics | 4:持股變動聲明-股東 GC Corp.
Artiva Biotherapeutics | 4:持股變動聲明-董事 Huh Yong-Jun
Artiva Biotherapeutics | 4:持股變動聲明-高管 Aslan Fred
Artiva Biotherapeutics | S-8:員工福利計劃證券登記
Artiva Biotherapeutics | 8-K:重大事件
Artiva Biotherapeutics | 424B4:募資說明書
Artiva Biotherapeutics | SEC STAFF LETTER:其他
Artiva Biotherapeutics | EFFECT:其他
Artiva Biotherapeutics, Inc. | 3:首次持股聲明-股東 venBio Global Strategic Fund III, L.P.
Artiva Biotherapeutics, Inc. | 3:首次持股聲明-董事 RA CAPITAL MANAGEMENT, L.P.
Artiva Biotherapeutics, Inc. | 3:首次持股聲明-股東 5AM Partners VI, LLC
暫無數據